Fig 1: Validation of four proteins by mass spectrometry (MS). (A) Receiver operating characteristic (ROC) analysis for matrilin-2 (ID: O00339). (B) ROC analysis for mucin-13 (MUC13, ID: Q9H3R2). (C) ROC analysis for C-X-C motif chemokine 14 (ID: O95715). (D) ROC analysis for semaphorin-6D (ID: Q8NFY4). (E) 10-fold cross-validation in the discovery group of the four-protein panel. (F) ROC analysis for the four-protein panel.
Fig 2: Validation of four proteins by enzyme-linked immunosorbent assay (ELISA). (A) Receiver operating characteristic (ROC) analysis for semaphorin-6D (ID: Q8NFY4). (B) ROC analysis for mucin-13 (MUC13, ID: Q9H3R2). (C) ROC analysis for matrilin-2 (ID: O00339). (D) ROC analysis for C-X-C motif chemokine 14 (ID: O95715). (E) 10-fold cross-validation of the four-protein panel. (F) 10-fold cross-validation of the panel consisting of semaphorin-6D and mucin-13.
Supplier Page from Thermo Fisher Scientific for Human Matrilin-2 ELISA Kit